August 30, 2016 / 1:17 PM / a year ago

BUZZ-Orexigen Therapeutics Inc: Up after signing deal with Valeant

** Drugmaker's shares up 12 pct at $4.3 premarket

** Signs deal with Valeant Pharmaceuticals International Inc for its weight loss drug, Contrave

** Valeant will be responsible for obtaining Canadian regulatory approval, commercialization activity and expenses for the drug

** Orexigen expects Valeant to file with Health Canada for regulatory approval by January

** Contrave was approved by U.S. FDA in 2014

** Up to Monday's close, stock had fallen 86.2 pct YTD

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below